<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PRF</journal-id>
<journal-id journal-id-type="hwp">spprf</journal-id>
<journal-id journal-id-type="nlm-ta">Perfusion</journal-id>
<journal-title>Perfusion</journal-title>
<issn pub-type="ppub">0267-6591</issn>
<issn pub-type="epub">1477-111X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0267659112458960</article-id>
<article-id pub-id-type="publisher-id">10.1177_0267659112458960</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>In vitro comparison of two different methods of cell washing</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Smith</surname><given-names>T</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Riley</surname><given-names>W</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>FitzGerald</surname><given-names>D</given-names></name>
</contrib>
<aff id="aff1-0267659112458960">Brigham and Women’s Hospital, Boston, Massachusetts, USA</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0267659112458960">Trevor Smith Brigham and Women’s Hospital 75 Francis St Boston, MA 02115 USA Email: <email>tsmith17@partners.org</email></corresp>
<fn fn-type="other">
<p>Presented at the 33<sup>rd</sup> Annual Seminar of The American Academy of Cardiovascular Perfusion, New Orleans, Louisiana, 26–29 January 2012</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>1</issue>
<fpage>34</fpage>
<lpage>37</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>The storage of red blood cells (RBC) results in increased concentrations of plasma free hemoglobin, potassium, glucose, and lactate, among other undesirable substances. These concentrations continue to increase as RBC products age and can cause deleterious effects to the patient. In the setting of cardiac surgery, the autotransfusion devices are routinely used to wash blood that is shed from the surgical site. These devices could also be used to wash stored RBC units obtained from the blood bank. The objective of this study was to compare the product created by washing a unit of RBCs with the AutoLog autotransfusion device in the operating room to the washed products from a standard cell washer in the blood bank.</p>
<p>Eleven outdated RBC units (stored for &gt;42 days at 4°C) were split in half. One half was washed using the Medtronic AutoLog device; the other half was washed using the blood bank’s Cobe 2991 Cell Processor. Analytes were measured on samples from the unwashed parent unit and from the washed daughter units. The parameters measured included hematocrit, free hemoglobin, lactate, lactate dehydrogenase (LDH), potassium, glucose, and pH.</p>
<p>When compared to the original untreated RBCs, the glucose, lactate, and potassium levels were decreased when washed in an autotranfusion device. Additionally, the free hemoglobin and LDH levels were significantly lower with the Medtronic Autolog cell saver than in the COBE 2991 Cell Processor.</p>
<p>Washing the RBC donor units in an autotransfusion device prior to transfusion can effectively attenuate the increases seen in glucose, potassium, free hemoglobin, and LDH associated with RBC storage lesion.</p>
</abstract>
<kwd-group>
<kwd>Intraoperative cell washing</kwd>
<kwd>autotransfusion</kwd>
<kwd>red blood cell storage</kwd>
<kwd>blood transfusion</kwd>
<kwd>cell saver</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0267659112458960" sec-type="intro">
<title>Introduction</title>
<p>RBC units can be stored for 21 to 42 days, depending on the preservative, and the median storage time prior to transfusion in the United States is 15 days.<sup><xref ref-type="bibr" rid="bibr1-0267659112458960">1</xref></sup> Both 2,3- diphosphoglycerate (2,3-DPG) and adenosine triphosphate (ATP) are significantly depleted.<sup><xref ref-type="bibr" rid="bibr2-0267659112458960">2</xref><xref ref-type="bibr" rid="bibr3-0267659112458960"/><xref ref-type="bibr" rid="bibr4-0267659112458960"/>-<xref ref-type="bibr" rid="bibr5-0267659112458960">5</xref></sup> The decrease in ATP causes a decrease in many cellular processes, including glucose transport.<sup><xref ref-type="bibr" rid="bibr6-0267659112458960">6</xref></sup> In as little as two weeks after collection, donor RBCs show an increase in potassium, extracellular lactate and pCO<sub>2</sub>, with a decrease in pH and bicarbonate.<sup><xref ref-type="bibr" rid="bibr7-0267659112458960">7</xref></sup></p>
<p>Several observational studies have suggested harmful effects of transfusing RBC units in regards to storage time. Donor RBC units greater than two weeks old have been shown to cause a higher rate of in-hospital mortality, longer time of intubation, renal failure and sepsis when compared to blood under two weeks old.<sup><xref ref-type="bibr" rid="bibr8-0267659112458960">8</xref></sup> Additionally, Zallen et al. determined that the age of RBCs, RBC units older than 14 days and RBC units older than 21 days are all independent risk factors for developing multiple organ failure after transfusion.<sup><xref ref-type="bibr" rid="bibr9-0267659112458960">9</xref></sup></p>
<p>The use of a mechanical autotransfusion device in the operating room is a recognized method of avoiding allogeneic blood transfusion during cardiac surgery.<sup><xref ref-type="bibr" rid="bibr10-0267659112458960">10</xref><xref ref-type="bibr" rid="bibr11-0267659112458960"/>-<xref ref-type="bibr" rid="bibr12-0267659112458960">12</xref></sup> The cell saver device collects shed blood from the operating field and then uses a centrifuge to spin off the lower density cells present in the bowl. This process creates a product that is extremely rich in RBCs and devoid of many undesirable constituents originally present in the shed volume. The transfusion of a unit of autologous blood from a cell saver device has been shown to reduce circulating systemic inflammatory markers and remove most cytokines, with no unfavorable CNS events, no increase in infection, and no elevated hemolysis or fat emboli.<sup><xref ref-type="bibr" rid="bibr13-0267659112458960">13</xref><xref ref-type="bibr" rid="bibr14-0267659112458960"/><xref ref-type="bibr" rid="bibr15-0267659112458960"/><xref ref-type="bibr" rid="bibr16-0267659112458960"/><xref ref-type="bibr" rid="bibr17-0267659112458960"/>-<xref ref-type="bibr" rid="bibr18-0267659112458960">18</xref></sup></p>
<p>The prevalence of the cell saver devices in the operating room provides a potential mechanism for removing solutes from stored donor RBCs. By washing the units of packed RBCs, CO<sub>2</sub>, HCO<sub>3</sub>, potassium, lactate and glucose concentrations are all significantly reduced.<sup><xref ref-type="bibr" rid="bibr18-0267659112458960">18</xref></sup> The objective of this study was to determine the benefit of the product of RBCs from a cell saver device versus a cell washer in the blood bank when compared to the original parent unit of donor red blood cells.</p>
</sec>
<sec id="section2-0267659112458960" sec-type="materials|methods">
<title>Materials and methods</title>
<p>Eleven outdated donor RBC units were analyzed in this study. The RBC units were stored at 4°C for 42-49 days. A blood gas sample was taken from the unwashed parent unit, followed by the splitting of the unit into two equally sized daughter units. One daughter unit was washed in the blood bank by the Cobe 2991 Cell Processor (Terumo Medical Corporation, Ann Arbor, MI, USA), the other daughter unit was washed using a Medtronic Autolog cell saver device (Medtronic Ltd., Minneapolis, MN, USA) in the operating room. These devices were chosen because they are the current devices in operation at our institution. The Medtronic Autolog device was set up and operated according to manufacturer requirements and the half unit of donor blood was washed with normal 0.9% saline. There was no need for Ethics Committee approval as these units were outdated and, therefore, unsuitable for transfusion. After blood gas analysis, the units were promptly discarded.</p>
<p>Once washed by the devices, samples were taken from each unit and sent for blood gas analyses on the Rapidpoint 405 (Siemens, Munich, Germany). The values measured include hemoglobin (Hgb), hematocrit (Hct), potassium (K), glucose, bicarbonate (HCO<sub>3</sub>), pH, pCO<sub>2</sub>, pO<sub>2</sub>, plasma free hemoglobin (free Hgb), lactate dehydrogenase (LDH), and lactate.</p>
</sec>
<sec id="section3-0267659112458960" sec-type="results">
<title>Results</title>
<p><xref ref-type="table" rid="table1-0267659112458960">Table 1</xref> shows the mean values of the analytes measured and the p-value of the cell washers for each analyte compared to the parent unit. Compared to the unwashed parent RBC unit, the Cobe-washed units created increased Hgb and Hct. Conversely, the Medtronic Autolog-washed units displayed decreased Hgb and Hct levels.</p>
<table-wrap id="table1-0267659112458960" position="float">
<label>Table 1.</label>
<caption>
<p>Comparison of Medtronic Autolog and Cobe Cell Washer to Unwashed Parent Unit</p>
</caption>
<graphic alternate-form-of="table1-0267659112458960" xlink:href="10.1177_0267659112458960-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">Parent RBC Unit/ Pre-Washed</th>
<th align="left">Cobe-Washed RBC Unit</th>
<th align="left">p-value</th>
<th align="left">Medtronic Autolog-Washed RBC Unit</th>
<th align="left">p-value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hgb (g/dL)</td>
<td>19.3 ± 1.6</td>
<td>25.2 ± 2.1</td>
<td>0.0001</td>
<td>16.9 ± 1.6</td>
<td>0.0034</td>
</tr>
<tr>
<td>Hct (%)</td>
<td>61 ± 3</td>
<td>80 ± 2</td>
<td>0.0001</td>
<td>53 ± 4</td>
<td>0.0008</td>
</tr>
<tr>
<td>Free Hgb (g/dL)</td>
<td>224 ± 181</td>
<td>310 ± 187</td>
<td>0.1309</td>
<td>65 ± 31</td>
<td>0.0095</td>
</tr>
<tr>
<td>K (mmol/L)</td>
<td>61.53 ±15.5</td>
<td>4.63 ± 4.8</td>
<td>0.0002</td>
<td>0.95 ± 0.4</td>
<td>0.0002</td>
</tr>
<tr>
<td>Glucose (mg/dL)</td>
<td>626 ± 182</td>
<td>19 ± 23</td>
<td>&lt;.0001</td>
<td>51 ± 19</td>
<td>&lt;0.0001</td>
</tr>
<tr>
<td>LDH (U/L)</td>
<td>637 ± 695</td>
<td>952 ± 252</td>
<td>0.0874</td>
<td>121 ± 34</td>
<td>0.0017</td>
</tr>
<tr>
<td>Lactate (mmol/L)</td>
<td>26 ± 5</td>
<td>10 ± 3</td>
<td>&lt;.0001</td>
<td>7 ± 2</td>
<td>&lt;0.0001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0267659112458960">
<p>Data = mean ± standard deviation. Hgb: hemoglobin; Hct: hematocrit; LDH: lactate dehydrogenase.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>For cell stability after washing, the plasma free Hgb levels were significantly decreased when washed by the Autolog cell saver; however, the value was increased when washed by the Cobe. Additionally, the LDH values were significantly elevated in the Cobe processor whereas they were significantly reduced in the Medtronic Autolog cell saver.</p>
<p>The remaining values analyzed, potassium, glucose and lactate, were all significantly reduced by both the Cobe and Medtronic cell washers.</p>
</sec>
<sec id="section4-0267659112458960" sec-type="discussion">
<title>Discussion</title>
<p>The use of a cell saver in the operating room to reduce the use of RBC donor blood transfusion has been extensively studied.<sup><xref ref-type="bibr" rid="bibr10-0267659112458960">10</xref><xref ref-type="bibr" rid="bibr11-0267659112458960"/>-<xref ref-type="bibr" rid="bibr12-0267659112458960">12</xref></sup> The ability of these machines to wash shed RBC from an operating field can be extended to the washing of donor RBCs from the blood bank. <xref ref-type="table" rid="table1-0267659112458960">Table 1</xref> of this study shows that, when compared to the original parent unit of blood (which was anywhere from 0 to 7 days outdated past the 42 day guideline), the washed blood cells by the Medtronic Autolog in the operating room (OR) had significantly lower levels of potassium, glucose, LDH, lactate and plasma free hemoglobin.</p>
<p>Donor blood with high levels of potassium has the potential to cause hyperkalemia. Hyperkalemia can cause cardiac arrhythmias or lead to cardiac arrest in pediatric patients.<sup><xref ref-type="bibr" rid="bibr19-0267659112458960">19</xref></sup> The ability of an autotransfusion device to reduce hyperkalemia specifically for patients with end-stage renal failure and massive transfusion has previously been reported.<sup><xref ref-type="bibr" rid="bibr20-0267659112458960">20</xref></sup></p>
<p>Both cell washing devices effectively decreased the glucose storage lesion. An elevated peak glucose level during cardiopulmonary bypass has been shown to be an independent risk factor for mortality in both diabetic and non-diabetic patients.<sup><xref ref-type="bibr" rid="bibr21-0267659112458960">21</xref></sup> Furthermore, intraoperative hyperglycemia is an independent risk factor for perioperative complications, including death.<sup><xref ref-type="bibr" rid="bibr22-0267659112458960">22</xref></sup></p>
<p>The Cobe cell washer appears to lyse more cells than the Medtronic Autolog, evidenced by the elevated levels of plasma free hemoglobin and LDH. Previous reports have contrasted the levels of plasma free hemoglobin after a wash of a unit, citing the age of the blood as a possible culprit for the discrepancy.<sup><xref ref-type="bibr" rid="bibr23-0267659112458960">23</xref>,<xref ref-type="bibr" rid="bibr24-0267659112458960">24</xref></sup> However, the units used in this study were outdated and older than previous studies, which may indicate that the Autolog is gentler in handing these donor units. LDH, which is also a marker of cell lysis, was elevated in the Cobe washer units as well, but decreased in the Autolog washer units.</p>
<p>Of the parameters measured, Hct and Hgb showed worse results with the Medtronic Autolog cell washer than with the parent unit or the Cobe washer. This outcome is most likely the result of incomplete bowls being formed by the half units of daughter RBCs. Because the 250 mL centrifugal bowls on the cell saver could not be completely filled, the remaining volume was filled with the washing solution; in this case normal saline. The process causes a decrease in the final product’s Hct. Additionally, the volumes of the units were not recorded, bringing the product yield into question. Medtronic Ltd. reports having no data regarding returning washed cells from partially filled bowls and, therefore, does not recommend returning those cells. However, it is the authors’ view that the results in this study from incomplete bowls correlates with completely filled bowls. Completely filled bowls would show even more removal of the analytes measured as there would be more in the original product to be removed.</p>
<p>Another limitation of this study is the sample size. Only eleven outdated units were analyzed, a value that may be too small to make a significant find in the context of the red blood cell storage lesion. Additionally, in both the Cobe and Autolog units, the washed units were as acidotic as the unwashed units. The low pH causes a decrease in 2,3-DPG because 2,3-DPG requires a physiologic pH to be created.<sup><xref ref-type="bibr" rid="bibr25-0267659112458960">25</xref>,<xref ref-type="bibr" rid="bibr26-0267659112458960">26</xref></sup> It is possible that this is the result of washing the units with normal saline as opposed to a more neutral solution such as Normosol® (Hospira, Lake Forest, IL).</p>
<p>When comparing the blood bank cell washer versus the operating room cell saver, the results are very similar. However, the Cobe appears to lyse more cells, which is evident by the elevated LDH and free Hgb levels. The process involved in the two washers appears to favor an OR cell washer as well. The cost of washing in the OR is already included in the use of the cell saver with cardiac surgery and no additional disposals need to be set up by the blood bank. Multiple units of RBCs from different donors are capable of being washed by a single disposable cell washer kit. The units that are washed in the OR are most likely going to be used for that patient. Also, there is no time delay from washing to transfusion from the blood bank and units washed will be used, not washed and then decided that they are not needed. Additionally, a delay after washing to transfusion further reduces 2,3-DPG.<sup><xref ref-type="bibr" rid="bibr26-0267659112458960">26</xref></sup></p>
<p>In conclusion, this study aimed to determine the efficacy of washing donor units of RBCs to help attenuate the storage lesion associated with potassium, glucose, free hemoglobin and LDH. The different devices showed similar results in reducing the potassium and glucose seen in the outdated units. It is plausible that, prior to transfusion during cardiopulmonary bypass, where time may not be essential, donor units from the blood bank could be washed using a cell saver that is present in the OR. This practice will help decrease the administration of harmful substances accompanying the storage lesion.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of Interest Statement</label>
<p>The authors declare that there is no conflict of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0267659112458960">
<label>1.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Whitaker</surname><given-names>B</given-names></name>
<name><surname>Sullivan</surname><given-names>M</given-names></name>
</person-group>. <article-title>The 2005 Nationwide Blood Collection and Utiliization Survey Report</article-title>. <publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>AABB</publisher-name>, <year>2006</year>.</citation>
</ref>
<ref id="bibr2-0267659112458960">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Valeri</surname><given-names>CR</given-names></name>
<name><surname>Hirsch</surname><given-names>NM</given-names></name>
</person-group>. <article-title>Restoration in vivo of erythrocyte adenosine triphosphate, 2–3 diphosphoglycerate, postassium ion, and sodium ion concentrations following the transfusion of acid-citrate-dextrose-stored human red blood cells</article-title>. <source>J Lab Clin Med</source> <year>1969</year>; <volume>73</volume>: <fpage>722</fpage>–<lpage>733</lpage>.</citation>
</ref>
<ref id="bibr3-0267659112458960">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Valtis</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>Defective gas transport function of stored red blood-cells</article-title>. <source>Lancet</source> <year>1954</year>; <volume>266</volume>: <fpage>119</fpage>–<lpage>124</lpage>.</citation>
</ref>
<ref id="bibr4-0267659112458960">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dern</surname><given-names>RJ</given-names></name>
<name><surname>Brewer</surname><given-names>GJ</given-names></name>
<name><surname>Wiorkowski</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Studies on the preservation of human blood. II. The relationship of erythrocyte adenosine triphosphate levels and other in vitro measures to red cell storageablity</article-title>. <source>J Lab Clin Med</source> <year>1967</year>; <volume>69</volume>: <fpage>968</fpage>–<lpage>978</lpage>.</citation>
</ref>
<ref id="bibr5-0267659112458960">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Raat</surname><given-names>NJ</given-names></name>
<name><surname>Verhoeven</surname><given-names>AJ</given-names></name>
<name><surname>Mik</surname><given-names>EG</given-names></name>
<etal/>
</person-group>. <article-title>The effect of storage time of human red cells on intestinal microcirculatory oxygenation in a rat isovolemic exchange model</article-title>. <source>Crit Care Med</source> <year>2005</year>; <volume>33</volume>: <fpage>39</fpage>–<lpage>45</lpage>; <comment>discussion 238–239</comment>.</citation>
</ref>
<ref id="bibr6-0267659112458960">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Almac</surname><given-names>E</given-names></name>
<name><surname>Ince</surname><given-names>C</given-names></name>
</person-group>. <article-title>The impact of storage on red cell function in blood transfusion</article-title>. <source>Best Pract Res Clin Anaesthesiol</source> <year>2007</year>; <volume>21</volume>: <fpage>195</fpage>–<lpage>208</lpage>.</citation>
</ref>
<ref id="bibr7-0267659112458960">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hess</surname><given-names>JR</given-names></name>
<name><surname>Hill</surname><given-names>HR</given-names></name>
<name><surname>Oliver</surname><given-names>CK</given-names></name>
<etal/>
</person-group>. <article-title>Twelve-week RBC storage</article-title>. <source>Transfusion</source> <year>2003</year>; <volume>43</volume>: <fpage>867</fpage>–<lpage>872</lpage>.</citation>
</ref>
<ref id="bibr8-0267659112458960">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koch</surname><given-names>CG</given-names></name>
<name><surname>Li</surname><given-names>L</given-names></name>
<name><surname>Sessler</surname><given-names>DI</given-names></name>
<etal/>
</person-group>. <article-title>Duration of red-cell storage and complications after cardiac surgery</article-title>. <source>N Eng J Med</source> <year>2008</year>; <volume>358</volume>: <fpage>1229</fpage>–<lpage>1239</lpage>.</citation>
</ref>
<ref id="bibr9-0267659112458960">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zallen</surname><given-names>G</given-names></name>
<name><surname>Offner</surname><given-names>PJ</given-names></name>
<name><surname>Moore</surname><given-names>EE</given-names></name>
<etal/>
</person-group>. <article-title>Age of transfused blood is an independent risk factor for postinjury multiple organ failure</article-title>. <source>Am J Surg</source> <year>1999</year>; <volume>178:</volume> <fpage>570</fpage>–<lpage>572</lpage>.</citation>
</ref>
<ref id="bibr10-0267659112458960">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huet</surname><given-names>C</given-names></name>
<name><surname>Slami</surname><given-names>LR</given-names></name>
<name><surname>Fergusson</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. Internation Study of Perioperative Transfusion (ISPOT) Investigators</article-title>. <source>Anesth Analg</source> <year>1999</year>; <volume>89</volume>: <fpage>861</fpage>–<lpage>869</lpage>.</citation>
</ref>
<ref id="bibr11-0267659112458960">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McGill</surname><given-names>N</given-names></name>
<name><surname>O’Shaughnessy</surname><given-names>D</given-names></name>
<name><surname>Pickering</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Mechanical methods of reducing blood transfusion in cardiac surgery randomized controlled trial</article-title>. <source>BMJ</source> <year>2002</year>; <volume>324</volume>: <fpage>1299</fpage>.</citation>
</ref>
<ref id="bibr12-0267659112458960">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferraris</surname><given-names>VA</given-names></name>
<name><surname>Ferraris</surname><given-names>SP</given-names></name>
<name><surname>Saha</surname><given-names>SP</given-names></name>
<etal/>
</person-group>. <article-title>Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the The Society of Cardiovascular Anesthesiologists clinical practice guideline</article-title>. <source>Ann Thorac Surg</source> <year>2007</year>; <volume>83</volume>(<supplement>5 suppl</supplement>): <fpage>S27</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr13-0267659112458960">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Svenmarker</surname><given-names>S</given-names></name>
<name><surname>Engstrom</surname><given-names>KG</given-names></name>
</person-group>. <article-title>The inflammatory response to recycled pericardial suction blood and the influence of cell-saving</article-title>. <source>Scand Cardiovasc J</source> <year>2003</year>; <volume>37</volume>: <fpage>158</fpage>–<lpage>164</lpage>.</citation>
</ref>
<ref id="bibr14-0267659112458960">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ishida</surname><given-names>T</given-names></name>
<name><surname>Nakano</surname><given-names>K</given-names></name>
<name><surname>Nakatani</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Relation between intraoperative salvaged blood transfusion and postoperative infection after cardiac surgery</article-title>. <source>Kyobu Geka</source> <year>2002</year>; <volume>55</volume>: <fpage>763</fpage>–<lpage>767</lpage>.</citation>
</ref>
<ref id="bibr15-0267659112458960">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jewell</surname><given-names>AE</given-names></name>
<name><surname>Akowuah</surname><given-names>EF</given-names></name>
<name><surname>Suvarna</surname><given-names>SK</given-names></name>
<name><surname>Braidley</surname><given-names>P</given-names></name>
<name><surname>Hopkinson</surname><given-names>D</given-names></name>
<name><surname>Cooper</surname><given-names>G</given-names></name>
</person-group>. <article-title>A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery</article-title>. <source>Eur J Cardiothorac Surg</source> <year>2003</year>; <volume>23</volume>: <fpage>633</fpage>–<lpage>636</lpage>.</citation>
</ref>
<ref id="bibr16-0267659112458960">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Amand</surname><given-names>T</given-names></name>
<name><surname>Pincemail</surname><given-names>J</given-names></name>
<name><surname>Blaffart</surname><given-names>F</given-names></name>
<name><surname>Larbuisson</surname><given-names>R</given-names></name>
<name><surname>Limet</surname><given-names>R</given-names></name>
<name><surname>Defraigne</surname><given-names>JO</given-names></name>
</person-group>. <article-title>Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit</article-title>. <source>Perfusion</source> <year>2002</year>; <volume>17</volume>: <fpage>117</fpage>–<lpage>123</lpage>.</citation>
</ref>
<ref id="bibr17-0267659112458960">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Deleuze</surname><given-names>P</given-names></name>
<name><surname>Intrator</surname><given-names>L</given-names></name>
<name><surname>Liou</surname><given-names>A</given-names></name>
<name><surname>Contremoulins</surname><given-names>I</given-names></name>
<name><surname>Cachera</surname><given-names>JP</given-names></name>
<name><surname>Loisance</surname><given-names>DY</given-names></name>
</person-group>. <article-title>Complement activation and use of a cell saver in cardiopulmonary bypass</article-title>. <source>ASAIO Trans</source> <year>1990</year>; <volume>36</volume>: <fpage>M179</fpage>–<lpage>181</lpage>.</citation>
</ref>
<ref id="bibr18-0267659112458960">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gu</surname><given-names>YJ</given-names></name>
<name><surname>Vermeijden</surname><given-names>WJ</given-names></name>
<name><surname>de Vries</surname><given-names>AJ</given-names></name>
<etal/>
</person-group>. <article-title>Influence of mechanical cell salvage on red blood cell aggregation, deformability, and 2,3-diphosphogylerate in patients undergoing cardiac surgery with cardiopulmonary bypass</article-title>. <source>Ann Thorac Surg</source> <year>2008</year>; <volume>86</volume>: <fpage>1570</fpage>–<lpage>1575</lpage>.</citation>
</ref>
<ref id="bibr19-0267659112458960">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buntain</surname><given-names>SG</given-names></name>
<name><surname>Pabari</surname><given-names>M</given-names></name>
</person-group>. <article-title>Massive transfusion and hyperkalaemic cardiac arrest in craniofacial surgery in a child</article-title>. <source>Anaesth Intensive Care</source> <year>1999</year>; <volume>27</volume>: <fpage>530</fpage>–<lpage>533</lpage></citation>
</ref>
<ref id="bibr20-0267659112458960">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knichwitz</surname><given-names>G</given-names></name>
<name><surname>Zahl</surname><given-names>M</given-names></name>
<name><surname>Van Aken</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Intraoperative washing of long-stored packed red blood cells by using an autotransfusion device prevents hyperkalemia</article-title>. <source>Anesth Analg</source> <year>2002</year>; <volume>95</volume>: <fpage>324</fpage>–<lpage>325</lpage>.</citation>
</ref>
<ref id="bibr21-0267659112458960">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Doenst</surname><given-names>T</given-names></name>
<name><surname>Wijeysundera</surname><given-names>D</given-names></name>
<name><surname>Karkouti</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery</article-title>. <source>J Thorac Cardiac Surgery</source> <year>2005</year>; <volume>130</volume>: <fpage>1140</fpage>–<lpage>1149</lpage>.</citation>
</ref>
<ref id="bibr22-0267659112458960">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gandhi</surname><given-names>GY</given-names></name>
<name><surname>Nuttall</surname><given-names>GA</given-names></name>
<name><surname>Abel</surname><given-names>MD</given-names></name>
<etal/>
</person-group>. <article-title>Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients Mayo Clin Proc</article-title> <year>2005</year>; <volume>80</volume>: <fpage>862</fpage>–<lpage>866</lpage>.</citation>
</ref>
<ref id="bibr23-0267659112458960">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vroege</surname><given-names>R</given-names></name>
<name><surname>Wildevuur</surname><given-names>WR</given-names></name>
<name><surname>Muradin</surname><given-names>JA</given-names></name>
<etal/>
</person-group>. <article-title>Washing of stored red blood cells by an autotransfusion device before transfusion</article-title>. <source>Vox Sang</source> <year>2007</year>; <volume>92</volume>: <fpage>130</fpage>–<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr24-0267659112458960">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grabmer</surname><given-names>C</given-names></name>
<name><surname>Holmberg</surname><given-names>J</given-names></name>
<name><surname>Popovsky</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Up to 21-day banked red blood cells collected by apheresis and stored for 14 days after automated wash at different times of storage</article-title>. <source>Vox Sang</source> <year>2006</year>; <volume>90</volume>: <fpage>40</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr25-0267659112458960">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hogman</surname><given-names>CF</given-names></name>
<name><surname>Meryman</surname><given-names>HT</given-names></name>
</person-group>. <article-title>Red blood cells intended for transfusion: quality criteria revisited</article-title>. <source>Transfusion</source> <year>2006</year>; <volume>46</volume>: <fpage>137</fpage>–<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr26-0267659112458960">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weisbach</surname><given-names>V</given-names></name>
<name><surname>Riego</surname><given-names>W</given-names></name>
<name><surname>Strasser</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>The in vitro quality of washed, prestorage leukocyte-depleted red blood cell concentrates</article-title>. <source>Vox Sang</source> <year>2004</year>; <volume>87</volume>: <fpage>19</fpage>–<lpage>26</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>